Summaries of published research, with citations. For research use only. Not for human consumption.

• Tesamorelin Mechanism of Action: How a GHRH Analog WorksOctober 17, 2026
  Research Use Only. This article summarizes published laboratory, preclinical, and clinical-trial literature on tesamorelin, a synthetic GHRH analog. It is not medical advice. Vital Tides materials are intended for controlled laboratory and analytical research only—not for human or veterinary consumption,… Read more: Tesamorelin Mechanism of Action: How a GHRH Analog Works
• BPC-157 Mechanism of Action: What Preclinical Research ShowsOctober 15, 2026
  Research Use Only. This article summarizes laboratory and preclinical findings about gastric pentadecapeptide BPC 157. It is not medical advice. BPC-157 is not FDA-approved for medical use. Vital Tides materials are intended for controlled laboratory and analytical research only—not for… Read more: BPC-157 Mechanism of Action: What Preclinical Research Shows
• Semaglutide Explained: How It Works, What the Research Shows, Side Effects & Common QuestionsOctober 14, 2026
  Semaglutide is one of the most researched GLP-1 receptor agonists, and it has generated thousands of questions about weight loss, Ozempic, belly fat, side effects, appetite, and what happens after treatment stops. But there is an important distinction to make… Read more: Semaglutide Explained: How It Works, What the Research Shows, Side Effects & Common Questions

• Retatrutide Research Peptide: What It Is, How It Works & What the Research Shows

  October 1, 2026
  If you’ve been hearing about retatrutide, you’ve probably noticed that it’s being discussed as a new kind of weight management medication. But what exactly is retatrutide, how does it work, and what does the research actually tell us? Retatrutide, also… Read more: <h1>Retatrutide Research Peptide: What It Is, How It Works & What the Research Shows</h1>